Trupanion (NASDAQ:TRUP – Get Free Report) had its price objective lifted by analysts at Stifel Nicolaus from $42.00 to $44.00 in a research report issued on Monday,Benzinga reports. The brokerage currently has a “hold” rating on the financial services provider’s stock. Stifel Nicolaus’ price target indicates a potential downside of 10.51% from the stock’s current price.
Other analysts also recently issued research reports about the company. Piper Sandler raised their price objective on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Bank of America upped their price target on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a report on Friday, September 20th. Finally, Northland Securities raised their price objective on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $45.33.
Get Our Latest Stock Analysis on Trupanion
Trupanion Trading Down 0.8 %
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.09. The business had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. Trupanion’s revenue for the quarter was up 14.6% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.10) earnings per share. As a group, sell-side analysts forecast that Trupanion will post -0.23 EPS for the current year.
Insiders Place Their Bets
In other news, CFO Fawwad Qureshi sold 9,867 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $53.08, for a total value of $523,740.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Emily Dreyer sold 900 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $54.55, for a total value of $49,095.00. Following the completion of the sale, the senior vice president now owns 23,808 shares in the company, valued at approximately $1,298,726.40. This trade represents a 3.64 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 28,405 shares of company stock valued at $1,512,482 in the last 90 days. 5.50% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Trupanion
A number of institutional investors have recently made changes to their positions in TRUP. Quest Partners LLC acquired a new stake in shares of Trupanion during the third quarter worth $37,000. Wilmington Savings Fund Society FSB bought a new stake in shares of Trupanion in the third quarter valued at approximately $54,000. GAMMA Investing LLC grew its position in Trupanion by 70.4% during the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after buying an additional 596 shares in the last quarter. Headlands Technologies LLC acquired a new position in Trupanion in the 2nd quarter valued at $162,000. Finally, Entropy Technologies LP acquired a new position in Trupanion in the 3rd quarter valued at $202,000.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
- Five stocks we like better than Trupanion
- Golden Cross Stocks: Pattern, Examples and Charts
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- What is a support level?
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- What is the S&P/TSX Index?
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.